Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 14,907 | 17,555 | 15,402 | 13,385 | 17,220 |
| Cost of Goods | 2,739 | 2,669 | 2,082 | 3,041 | 2,438 |
| Gross Profit | 12,168 | 14,886 | 13,320 | 10,344 | 14,782 |
| Operating Expenses | 32,405 | 32,793 | 33,603 | 33,241 | 35,434 |
| Operating Income | -19,498 | -17,238 | -20,201 | -22,856 | -20,214 |
| Other Income | 358 | 392 | 243 | 561 | 424 |
| Pre-tax Income | -19,140 | -16,846 | -19,958 | -22,295 | -19,790 |
| Income Tax | -559 | -215 | -396 | N/A | -10 |
| Net Income Continuous | -18,581 | -16,631 | -19,562 | -22,295 | -19,780 |
| Net Income | $-18,581 | $-16,631 | $-19,562 | $-22,295 | $-19,780 |
| EPS Basic Total Ops | -0.89 | -0.78 | -0.92 | -1.05 | -0.93 |
| EPS Basic Continuous Ops | -0.87 | -0.78 | -0.92 | -1.05 | -0.93 |
| EPS Diluted Total Ops | -0.89 | -0.78 | -0.92 | -1.05 | -0.93 |
| EPS Diluted Continuous Ops | -0.87 | -0.78 | -0.92 | -1.05 | -0.93 |
| EBITDA(a) | $-18,067 | $-15,652 | $-18,553 | $-21,346 | $-18,815 |